膳食纤维与肠易激综合征:个性化医学时代将功能特性转化为临床价值
这篇叙述性综述探讨膳食纤维的功能特性及其在肠易激综合征患者中引发的生理反应,以探索将相关知识应用于纤维补充剂的精准使用。关键发现是:不同纤维引发高度不同的生理反应,这些反应与其功能特性而非溶解性相关;当前证据集中于纤维作为单一疗法针对整体IBS症状,未尝试利用功能特性产生特定症状靶向效应或作为辅助疗法。纤维治疗个性化可针对多个治疗目标,包括正常化排便习惯、调节肠道菌群功能趋向健康及纠正其他饮食疗法的微生物效应。
要点
- 不同纤维的生理反应取决于功能特性而非溶解性。
- 当前证据多将纤维作为整体IBS症状的单药疗法。
- 个性化纤维治疗可针对排便习惯、菌群功能等多个目标。
核心结论
- 理解特定纤维的胃肠道反应并结合个体生理,是未来个性化纤维治疗以增强IBS个性化管理的方向。
研究设计与样本
- 叙述性综述,评估膳食纤维功能特性及其在IBS患者中引发的生理反应,以探索精准使用纤维补充剂。
主要发现
- 不同纤维引发高度不同的生理反应,与功能特性而非溶解性相关。
- 当前证据集中于纤维作为单一疗法针对整体IBS症状,未利用功能特性产生特定症状靶向效应或作为辅助疗法。
- 个性化纤维治疗可针对多个目标:正常化排便习惯、调节肠道菌群功能趋向健康、纠正其他饮食疗法的微生物效应。
- 成块性低发酵纤维可用于调节排便习惯指标;慢发酵纤维可增强肠道菌群活性;两者组合可能兼具益处并优化结肠不同区域的菌群活性。
临床怎么用
- 根据纤维功能特性而非溶解性选择纤维类型,以针对IBS患者特定症状目标。
- 可考虑将纤维作为辅助疗法或联合使用不同纤维类型以优化菌群活性及排便习惯。
局限性
- 当前证据多将纤维作为整体IBS症状的单药疗法,缺乏针对特定症状靶向或辅助疗法的研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Clinical guidelines in the use of fibre supplementation for patients with IBS provide one-size-fits-all advice, which has limited value. This narrative review addresses data and concepts around the functional characteristics of fibre and subsequent physiological responses induced in patients with IBS with a view to exploring the application of such knowledge to the precision use of fibre supplements. The key findings are that first, individual fibres elicit highly distinct physiological responses that are associated with their functional characteristics rather than solubility. Second, the current evidence has focused on the use of fibres as a monotherapy for IBS symptoms overall without attempting to exploit these functional characteristics to elicit specific, symptom-targeted effects, or to use fibre types as adjunctive therapies. Personalisation of fibre therapies can therefore target several therapeutic goals. Proposed goals include achieving normalisation of bowel habit, modulation of gut microbiota function towards health and correction of microbial effects of other dietary therapies. To put into perspective, bulking fibres that are minimally fermented can offer utility in modulating indices of bowel habit; slowly fermented fibres may enhance the activities of the gut microbiota; and the combination of both fibres may potentially offer both benefits while optimising the activities of the microbiota throughout the different regions of the colon. In conclusion, understanding the GI responses to specific fibres, particularly in relation to the physiology of the individual, will be the future for personalising fibre therapy for enhancing the personalised management of patients with IBS.
引用
- So D, Gibson PR, Muir JG, et al. Dietary fibres and IBS: translating functional characteristics to clinical value in the era of personalised medicine. Gut. 2021. PMID: 34417199. doi:10.1136/gutjnl-2021-324891
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。